Residents Take Part in Global Simulation Wet Lab On Saturday, January 8, our three senior residents joined UW ophthalmologist Jennifer Larson, MD, for a global surgical simulation wet lab training at the VA Hospital in …
Amy Pikalek
Remembering Dr. Clare Hutson
The UW Department of Ophthalmology and Visual Sciences is saddened to announce the passing of our friend and longtime colleague, Clare F. Hutson, MD, on January 10, 2022. He was 95 years old. A Badger …
Meet the Newest DOVS Faculty Member: Shaoqin (Sarah) Gong
The UW Department of Ophthalmology and Visual Sciences is pleased to welcome Shaoqin (Sarah) Gong, PhD, as our newest faculty member. Gong comes to DOVS with more than 20 years of experience as a scientist, …
DOVS and UW School of Veterinary Medicine Team Up for Ocular Pathology Day
The UW Department of Ophthalmology and Visual Sciences (DOVS) and the UW School of Veterinary Medicine were proud to have successfully hosted another annual Ocular Pathology Day on September 17, 2021. The morning began virtually …
CLN-0500
A Randomized, Parallel-Arm, Active Control, Multicenter Study Assessing the Safety and Efficacy of Dextenza for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
ATMOSPHERE
A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD (ATMOSPHERE)
UNITY
A Phase 2a, Prospective, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Safety, Tolerability and Evidence of Activity of a Single Intravitreal Injection of UBX1325 in Patients with Diabetic Macular Edema
PEP
Patient Experience and Preference (PEP) Study in nAMD and DME
Teaming Up for Gene Therapy
*This article originally appeared in the McPherson Eye Research Institute Summer 2021 InSights Newsletter Millions of Americans currently battle inherited visual disorders, armed with very few therapeutic options. Recent advances in genome editing, which many believe …